Labcorp Holdings Inc. leverages strategic moves like the Fortrea spin-off and Invitae acquisition to drive growth. Read more ...
The new interpreter will run Python programs as much as 30% faster, with no changes to existing code required. A beta of ...
Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured presentation at the SWCR 2025 Conference on ...
During a recent financial call, spotted by VGC, Sony president Hiroki Totoki reaffirms plans to make more family-oriented and live service games following the success of Helldivers 2 and Astro Bot, ...
19h
Zacks.com on MSNIs Fidelity Select Health Care (FSPHX) a Strong Mutual Fund Pick Right Now?Sector - Health fund seekers should consider taking a look at Fidelity Select Health Care (FSPHX). FSPHX possesses a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting ...
Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and ...
Realty Income has its most attractive valuation in a decade, with more interest rate cuts on the horizon. Discover why I ...
In the 20-week double-blind period of the study, a similar proportion of patients had adverse events (AEs) in the mitapivat and placebo arms and there were no discontinuations of study treatment due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results